Received Oct 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 4L454 | — |
received a dose of Kinrix supposed to receive Pediarix dose number 3; received a dose of Kinrix supposed to receive Pediarix dose number 3; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa-IPV (Kinrix) (batch number 4L454, expiry date 16-OCT-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. Previously administered products included Pediarix (received first dose on an unknown date) and Pediarix (received second dose on an unknown date). On an unknown date, the patient received the 3rd dose of Kinrix. The patient did not receive Pediarix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: received a dose of Kinrix supposed to receive Pediarix dose number 3) and wrong vaccine administered (Verbatim: received a dose of Kinrix supposed to receive Pediarix dose number 3). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-OCT-2025 A medical assistant reported that a 15-month-old received a dose of Kinrix. He was supposed to receive Pediarix dose number 3.